Health
PET/CT insights predict immunotherapy response in patients with advanced lung cancer – Health Imaging
Checkpoint inhibitors target the PD-L1/PD1 signaling pathway and are commonly used to treat those with NSCLC. While this therapy can be highly effective, it only works for nearly 50% of patients.
In order to avoid treating those who likely wont respond,…
Continue Reading
-
General18 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News17 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News19 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland